Product
development
inquiry

Novarex
Official Blog

Financial information

Consolidated financial statements(Unit : ￦B)

Class 2020 2019 2018
Current assets

100,066

79,999

63,975
Non-current asset

115,435

74,374

42,346
Total assets

215,501

154,373

106,321
Current liabilities

57,761

38,862

26,034
Non-current liabilities

41,750

23,635

1,199
Total liabilities

99,511

62,497

27,233
Capital

4,502

4,502

4,502
Paid-in Capital in Excess of Par Value

31,997

31,997

31,997
Other Capital Surplus

316

-30

-66
Retained earnings

78,795

55,322

42,493
Non-controlling Interest

380

85

162
Total Equity

115,990

91,876

79,088

Consolidated Income Statement(Unit : ￦B)

Class 2020 2019 2018
Sales

222,832

159,101

107,311
Cost of Goods Sold

183,629

130,486

86,646
Gross Profit

39,203

28,615

20,665
Sales and General Administrative Expenses

12,210

12,310

9,330
Operating Income

26,993

16,305

11,335
Other Income

302

246

229
Other Expenses

56

183

456
Financial Income

1,406

846

465
Financial Expenses

1,843

201

85
Income Before Income Taxes

26,802

17,013

11,488
법인세비용

1,802

2,508

-2,335
Net Income

25,000

14,505

13,823
TOP